4
Changes in Ownership
OptimizeRx Corp Filed Acc 0001628280-25-044426
Chief Business Officer acquired 10,417 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| D'Silva Andrew J. Chief Business Officer | 2025-08-21 | Grant or award | +10,417 | 47,514 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| D'Silva Andrew J. Chief Business Officer | 2025-08-21 | Grant or award · Stock Option | +23,437 | 23,437 | D: show line 2 in the form |
Loading xslF345X05/wk-form4_1759850764.xml…